Skyhook accelerates the discovery and development of differentiated therapeutics by accessing vast biological design spaces previously intractable with current state of the art technologies. Our differentiated platform employs efficient AI-guided design, synthesis, and functional screening of diverse programmable biomolecule libraries at unprecedented speed and scale. Skyhook is an RA Ventures* company. *RA Ventures is the venture focused division of RA Capital Management.
| Website | http://www.skyhook.bio |
| Employees | 14 (13 on RocketReach) |
| Industry | Biotechnology Research |
Looking for a particular Skyhook employee's phone or email?
Kevin Grosselin is the Co-Founder and Vice President, Head of Research of Skyhook.
13 people are employed at Skyhook.
Skyhook is based in Cambridge, Massachusetts.